No products in the cart.
#VisualAbstract: Time-of-infusion with immunotherapy may impact survival outcomes for patients with advanced melanoma
Click to read this study in Lancet Oncology.
Tag: advanced melanoma
#VisualAbstract: Acral lentiginous melanoma may be associated with higher rates of sentinel lymph node positivity compared to other melanoma subtypes
Click to read this study in JAMA Dermatology.
#VisualAbstract: Hereditary retinoblastoma survivors are at an increased risk for melanoma and non-melanoma skin cancers
Click to read this study in the Journal of Investigative Dermatology.
#VisualAbstract: Nivolumab plus ipilimumab may be less effective in females with melanoma compared to males
Click to read this study in JAMA Network Open.
The Management of Lesions to Exclude Melanoma schema may be a clinically useful and accurate classification system for melanocytic lesions
1. Pathologists demonstrated high accuracy in diagnosing melanocytic lesions using the Management of Lesions to Exclude Melanoma (MOLEM) classification system ...
Nivolumab plus ipilimumab improved long-term survival in patients with advanced melanoma
1. The 6.5-year progression-free survival for the nivolumab combination group, nivolumab group and in the ipilimumab group were 34%, 29% ...
Evening-dose immune checkpoint inhibitors were associated with worse survival outcomes
1. Receiving at least 20% of infusions after 1630h was associated with decreased overall survival in patients treated with immune-checkpoint ...
#VisualAbstract: High-dose glucocorticoids may be detrimental for the management of patients with advanced melanoma expieriencing immune-related adverse events
Click to read the study in Clinical Cancer Research.
#VisualAbstract: Presence of anti-telomerase CD4+ Th1 immunity is associated with better outcomes in patients with melanoma
Click to read the study in the Journal of Investigative Dermatology.
#VisualAbstract: Melanoma survival outcomes have improved between 2003 and 2019 amidst increasing incidence rates
Click to read the study in the European Journal of Cancer.
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.